New News information at Practical Patient Care New and updated information from News listed on www.practical-patient-care.com http://www.practical-patient-care.com/ en-us http://www.practical-patient-care.com/ New News information at Practical Patient Care http://www.practical-patient-care.com/content/images/logo_big.gif Sanofi secures EC approval for two enzyme replacement treatments for rare diseases http://www.practical-patient-care.com/news/newssanofi-secures-ec-approval-for-two-enzyme-replacement-treatments-for-rare-diseases-9809053 http://www.practical-patient-care.com/news/newssanofi-secures-ec-approval-for-two-enzyme-replacement-treatments-for-rare-diseases-9809053 by <br/> <br/> The European regulator approved Nexviadyme to treat the full spectrum of Pompe disease and Xenpozyme to treat non-Central Nervous System (CNS) manifestations of Acid Sphingomyelinase Deficiency (ASMD) Wed, 29 Jun 2022 08:34:00 GMT Novartis gets expanded EC approval for Cosentyx to include paediatric arthritic conditions http://www.practical-patient-care.com/news/newsnovartis-gets-expanded-ec-approval-for-cosentyx-to-include-paediatric-arthritic-conditions-9809104 http://www.practical-patient-care.com/news/newsnovartis-gets-expanded-ec-approval-for-cosentyx-to-include-paediatric-arthritic-conditions-9809104 by <br/> <br/> The expanded approval is based on data from the JUNIPERA trial, which showed that Cosentyx reduced the risk of flare and disease activity compared to placebo in paediatric patients with ERA and PsA Tue, 28 Jun 2022 08:00:00 GMT Astellas, Sutro partner to develop novel iADCs for cancer treatment http://www.practical-patient-care.com/news/newsastellas-sutro-partner-to-develop-novel-iadcs-for-cancer-treatment-9809082 http://www.practical-patient-care.com/news/newsastellas-sutro-partner-to-develop-novel-iadcs-for-cancer-treatment-9809082 by <br/> <br/> The partnership leverages the cancer-fighting potential of iADCs as a novel modality, enabled by Sutro’s ability to engineer complex conjugated antibodies and Astellas’ expertise in oncology research and development Tue, 28 Jun 2022 06:00:00 GMT Saudi Arabia to invest over $3bn in vaccines and vital medicines industry http://www.practical-patient-care.com/news/newssaudi-arabia-to-invest-over-3bn-in-vaccines-and-vital-medicines-industry-9806881 http://www.practical-patient-care.com/news/newssaudi-arabia-to-invest-over-3bn-in-vaccines-and-vital-medicines-industry-9806881 by <br/> <br/> The investment will be implemented in two stages where the first stage will focus on developing vaccines, plasma, and insulin technologies, while the second stage on the immunological and cancer drugs industry Mon, 27 Jun 2022 04:20:00 GMT US FDA expands Merck’s Vaxneuvance indication to include infants and children http://www.practical-patient-care.com/news/newsus-fda-expands-mercks-vaxneuvance-indication-to-include-infants-and-children-9806897 http://www.practical-patient-care.com/news/newsus-fda-expands-mercks-vaxneuvance-indication-to-include-infants-and-children-9806897 by <br/> <br/> The FDA approval was based on data from seven randomised, double-blind clinical studies that evaluated Vaxneuvance in infants, children and adolescents Thu, 23 Jun 2022 07:20:00 GMT Plans for the MEDICA 2022 and COMPAMED 2022 are picking up speed – registrations are still possible for all segments of the fair http://www.practical-patient-care.com/news/newsplans-for-the-medica-2022-and-compamed-2022-are-picking-up-speed-registrations-are-still-possible-for-all-segments-of-the-fair-9774688 http://www.practical-patient-care.com/news/newsplans-for-the-medica-2022-and-compamed-2022-are-picking-up-speed-registrations-are-still-possible-for-all-segments-of-the-fair-9774688 by <br/> <br/> Medical technology industry needs strong platforms while current challenges continue Wed, 15 Jun 2022 13:03:00 GMT Massachusetts authorities confirm first case of monkeypox in US http://www.practical-patient-care.com/news/newsmassachusetts-authorities-confirm-first-case-of-monkeypox-in-us-9766760 http://www.practical-patient-care.com/news/newsmassachusetts-authorities-confirm-first-case-of-monkeypox-in-us-9766760 by <br/> <br/> The US Centres for Disease Control and Prevention (CDC) has confirmed the first monkeypox infection, after conducting a confirmatory test Thu, 19 May 2022 06:35:00 GMT Biogen partners with MedRhythms to develop digital therapeutic for multiple sclerosis http://www.practical-patient-care.com/news/newsbiogen-partners-with-medrhythms-to-develop-digital-therapeutic-for-multiple-sclerosis-9766780 http://www.practical-patient-care.com/news/newsbiogen-partners-with-medrhythms-to-develop-digital-therapeutic-for-multiple-sclerosis-9766780 by <br/> <br/> MR-004 is an investigational prescription digital therapeutic that leverages a combination of sensors, software, and music based on Rhythmic Auditory Stimulation (RAS) Fri, 06 May 2022 05:15:00 GMT Charles River, Valo introduce Integrated AI drug discovery solution Logica http://www.practical-patient-care.com/news/newscharles-river-valo-introduce-integrated-ai-drug-discovery-solution-logica-9770354 http://www.practical-patient-care.com/news/newscharles-river-valo-introduce-integrated-ai-drug-discovery-solution-logica-9770354 by <br/> <br/> The turnkey drug discovery solution leverages Valo’s AI-powered Opal Computational Platform and Charles River’s preclinical expertise Thu, 28 Apr 2022 05:15:00 GMT WHO recommends use of Prizer’s oral antiviral for high-risk Covid-19 patients http://www.practical-patient-care.com/news/newswho-recommends-use-of-prizers-oral-antiviral-for-high-risk-covid-19-patients-9771199 http://www.practical-patient-care.com/news/newswho-recommends-use-of-prizers-oral-antiviral-for-high-risk-covid-19-patients-9771199 by <br/> <br/> The agency is recommending Pfizer’s Paxlovid for Covid-19 patients who are at high risk of developing severe diseases, such as unvaccinated, older, or immunosuppressed patients Fri, 22 Apr 2022 12:47:00 GMT